{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:28:16Z","timestamp":1782930496783,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bioorg.2021.105194","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T07:21:52Z","timestamp":1627024912000},"page":"105194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides"],"prefix":"10.1016","volume":"115","author":[{"given":"Cem","family":"Yamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise","family":"Inci Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsen","family":"Ozli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petek","family":"Ballar Kirmizibayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Erbaykent Tepedelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105194_b0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bioorg.2019.03.007","article-title":"Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors","volume":"87","author":"El-Azab","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2012.01144.x","article-title":"The role of carbonic anhydrase IX in hypoxia control in OSCC","volume":"42","author":"Perez-Sayans","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bioorg.2021.105194_b0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"30","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.105194_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bioorg.2021.105194_b0025","article-title":"Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2021.105194_b0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2019.02.044","article-title":"Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines","volume":"168","author":"Krasavin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2021.105194_b0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrases IX and XII: Highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105194_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2021.105194_b0050","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bjc.6600796","article-title":"Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma","volume":"88","author":"Watson","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2021.105194_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic Anhydrases: Role in pH control and cancer","volume":"28","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2021.105194_b0060","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2021.105194_b0065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cmdc.201800180","article-title":"Synthesis and biological evaluation of 4-sulfamoylphenyl\/sulfocoumarin carboxamides as selective inhibitors of carbonic anhydrase isoforms hCA II, IX, and XII","volume":"13","author":"Angapelly","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2021.105194_b0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, Patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2021.105194_b0080","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting Hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bioorg.2021.105194_b0085","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/molecules23081980","article-title":"Discovery of 4,5-dihydro-1H-thieno[2',3':2,3]thiepino [4,5-c]pyrazole-3-carboxamide derivatives as the potential epidermal growth factor receptors for tyrosine kinase inhibitors","volume":"23","author":"Ke","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.105194_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113281","article-title":"Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors","volume":"215","author":"Lin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1248\/cpb.c13-00676","article-title":"Novel 1H-pyrazole-3-carboxamide derivatives: synthesis, anticancer evaluation and identification of their DNA-binding interaction","volume":"62","author":"Lu","year":"2014","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bioorg.2021.105194_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2014.09.056","article-title":"Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines","volume":"87","author":"Cankara Pirol","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0105","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bmc.2015.02.038","article-title":"Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors","volume":"23","author":"Yasuda","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113351","article-title":"Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides","volume":"217","author":"Yamali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","article-title":"Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103222","article-title":"Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors","volume":"92","author":"Yamali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0135","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational approaches to improving selectivity in drug design","volume":"55","author":"Huggins","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0140","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0145","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14756366.2020.1801674","article-title":"Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents","volume":"35","author":"Krasavin","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0150","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00044-018-2242-5","article-title":"Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates","volume":"27","author":"Gul","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2021.105194_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103095","article-title":"Synthesis and biological evaluation of some new mono Mannich bases with piperazines as possible anticancer agents and carbonic anhydrase inhibitors","volume":"90","author":"Tugrak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0160","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.21873\/anticanres.13863","article-title":"Quantitative structure-cytotoxicity relationship of 2-styrylchromones","volume":"39","author":"Uesawa","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2021.105194_b0165","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2174\/1570180817999200520123510","article-title":"Aminoalkylated phenolic chalcones: Investigation of biological effects on acetylcholinesterase and carbonic anhydrase I and II as potential lead enzyme inhibitors","volume":"17","author":"Yamali","year":"2020","journal-title":"Lett Drug Des Discov"},{"key":"10.1016\/j.bioorg.2021.105194_b0170","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1871520617666170327123909","article-title":"Synthesis and cytotoxic activities of difluoro-dimethoxy chalcones","volume":"17","author":"Yamali","year":"2017","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"10.1016\/j.bioorg.2021.105194_b0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14756366.2016.1221825","article-title":"Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases","volume":"31","author":"Yamali","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0180","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00044-017-1911-0","article-title":"Synthesis and structure elucidation of 1-(2,5\/3,5-difluorophenyl)-3-(2,3\/2,4\/2,5\/3,4-dimethoxyphenyl)-2-propen-1-ones as anticancer agents","volume":"26","author":"Yamali","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2021.105194_b0185","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bmc.2016.01.047","article-title":"Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives","volume":"24","author":"Leung","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105194_b0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.bioorg.2021.105194_b0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2009.09.013","article-title":"Caspase-7: a protease involved in apoptosis and inflammation","volume":"42","author":"Lamkanfi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2021.105194_b0200","article-title":"Caspase functions in cell death and disease","volume":"1","author":"McIlwain","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bioorg.2021.105194_b0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2021.105194_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-2742-5_9","article-title":"The Western Blot","volume":"1318","author":"Hnasko","year":"2015","journal-title":"Methods Mol. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682100571X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682100571X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:28:34Z","timestamp":1758616114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682100571X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S004520682100571X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105194","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105194"}}